Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
Verified American Company Independently reviewed and approved · June 2026

AGILENT TECHNOLOGIES, INC. (A)

$138.57 -0.84% NYSE: A · 15-min delayed
  • SANTA CLARA, California
  • Public · NYSE: A
  • 18,100 employees
$38.3BMarket cap
$6.9BRevenue · FY2025
$1.3BNet income
18,100Employees
ANYSE
1999IPO

About AGILENT TECHNOLOGIES, INC.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

American Credentials

Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →

Reported figures

Financial summary

Revenue FY2025
$6.9B
Net income
$1.3B
Total assets
$12.7B
Market cap
$38.3B
Gross margin
52.4%
Operating margin
21.3%
Net margin
18.8%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$6.9B
Cost of revenue
$3.3B
Gross profit
$3.6B
Operating expenses
$2.2B
Operating income
$1.5B
Income tax
$132.0M
Net income
$1.3B
EPS (basic)
$4.59
EPS (diluted)
$4.57

Balance sheet

Total assets
$12.7B
Current assets
$4.6B
Total liabilities
$6.0B
Current liabilities
$2.3B
Shareholders’ equity
-$226.0M

Cash flow

Operating cash flow
$1.6B
Investing cash flow
-$394.0M
Financing cash flow
-$715.0M
Net cash flow
$459.0M

Statements via Polygon.io (SEC filings)

NYSE: A
$138.57 -0.84%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$110.24 $157.20

52-week range

Market cap
$38.3B
P/E ratio
30.3
EPS (diluted)
$4.57
Dividend yield
0.74%
Shares outstanding
276.1M
Open
Day range
Prev close
Volume
IPO date
Nov 18, 1999

Agilent Technologies, Inc. (A) Stock Price

  • Profitable — net income of $1.3B in FY2025.
  • Revenue grew 30% from FY2020 to FY2025.
  • Gross margin of 52.4%, net margin 18.8%.
  • Trading 12% below its 52-week high.
  • Pays a dividend yielding about 0.74% annually.
  • Valued at a price-to-earnings (P/E) ratio of 30.3.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review AGILENT TECHNOLOGIES, INC..

Write a review
Newsroom

News about AGILENT TECHNOLOGIES, INC.

News & sentiment via Polygon.io

FAQ

Agilent Technologies, Inc.: frequently asked questions

Is Agilent Technologies, Inc. an American company?

Yes — Agilent Technologies, Inc. is an American company headquartered in Santa Clara, California. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.

Where is Agilent Technologies, Inc. headquartered?

Agilent Technologies, Inc. is headquartered in Santa Clara, California, United States.

Is Agilent Technologies, Inc. publicly traded?

Yes — Agilent Technologies, Inc. is a publicly traded company. Its stock trades under the ticker symbol A on the NYSE.

What does Agilent Technologies, Inc. do?

Agilent Technologies, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →